First Time Loading...
I

Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 69.44 USD -1.28% Market Closed
Updated: May 4, 2024

Intra-Cellular Therapies Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intra-Cellular Therapies Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Cash from Financing Activities
$17.8m
CAGR 3-Years
-70%
CAGR 5-Years
92%
CAGR 10-Years
-8%
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
$8.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-12%
CAGR 5-Years
17%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Intra-Cellular Therapies Inc's Cash from Financing Activities?
Cash from Financing Activities
17.8m USD

Based on the financial report for Dec 31, 2023, Intra-Cellular Therapies Inc's Cash from Financing Activities amounts to 17.8m USD.

What is Intra-Cellular Therapies Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-8%

Over the last year, the Cash from Financing Activities growth was -96%. The average annual Cash from Financing Activities growth rates for Intra-Cellular Therapies Inc have been -70% over the past three years , 92% over the past five years , and -8% over the past ten years .